Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
OwnerDavid E. Berg, Lois Hill Berg +1inventors
InventorsDavid E. Berg, Lois Hill Berg, Harold H. Harrison
Life of this patent
Estimating the term…
Abstract
This invention relates to a method for using a novel combination of assays to detect minimal activation of the coagulation response for determining whether a patient whose initial clinical evaluation indicates chronic fatigue syndrome, fibromyalgia, and related conditions can be treated using anticoagulant therapies. If activation of the coagulation response is detected, the present invention further includes treatment of CFS, FM or related condition using anticoagulant therapies.
Claims8
A method for assisting in the diagnosis of chronic fatigue syndrome or fibromyalgia by determining a low level activation of the coagulation response comprising the steps of:
- a. performing a panel of four quantitative blood tests comprising (1) fibrinogen, (2) prothrombin fragment 1+2, (3) thrombin/antithrombin complexes, and (4) soluble fibrin monomer;
- b. observing the test results from the panel to determine whether two or more test results are abnormal, thereby indicating a low level activation of the coagulation response.
A method for assisting in the diagnosis of chronic fatigue syndrome or fibromyalgia by determining a low level activation of the coagulation response comprising the steps of:
- a. performing a panel of four quantitative blood tests comprising (1) fibrinogen, (2) prothrombin fragment 1+2, (3) thrombin/antithrombin complexes, (4) soluble fibrin monomer, and (5) platelet activity by flow cytometry;
- b. observing the test results from the panel to determine whether two or more test results are abnormal, thereby indicating a low level activation of the coagulation response.
Dependencies are inferred from the claim text.